Johnson & Johnson Moves Toward Major Talc Lawsuit Resolution
Johnson & Johnson has announced a proposed $5.5 billion settlement to resolve tens of thousands of lawsuits alleging that its talc-based products, including its well-known baby powder, caused ovarian cancer. The agreement could bring an end to one of the largest and longest-running product liability cases involving the healthcare company.
The proposed settlement covers around 76,000 remaining claims filed in federal and state courts across the United States. However, the deal will only become effective if at least 95% of eligible claimants agree to participate.
Settlement Aims to End Years of Legal Battles
The litigation has continued for more than a decade, with thousands of plaintiffs claiming prolonged use of talc-based products increased their risk of developing ovarian cancer. Johnson & Johnson has consistently denied these allegations, maintaining that scientific research supports the safety of its talc products and that they do not cause cancer.
Despite its position, the company said reaching a settlement would allow it to put the long-running legal dispute behind it and focus on its core healthcare and medical technology businesses.
Payment Structure and Legal Conditions
Under the proposed agreement, Johnson & Johnson plans to make an initial payment of up to $3 billion in 2027, with the remaining amount scheduled for later years. Total payouts could exceed the announced figure if participation levels and final terms require additional payments.
The settlement follows several recent legal developments, including favorable court rulings for the company that questioned whether plaintiffs could prove a direct link between talc products and individual ovarian cancer cases. Even so, both sides have chosen to pursue a negotiated resolution rather than continue years of courtroom litigation.
What Happens Next?
The proposed agreement is still subject to approval by the required percentage of claimants. If finalized, it would resolve nearly all remaining ovarian cancer-related talc lawsuits against Johnson & Johnson in the United States and close a major chapter in the company’s lengthy legal history surrounding its talc products.
